- ## The design of our REALISE study is now complete, and published
- #+BEGIN_VERSE
At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). We're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), which will evaluate its safety and efficacy
At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). We're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), a Phase IV clinical trial aimed at evaluating safety and effectiveness within large populations
The details of the trial have been published in clinicaltrials.gov and the Pan African Clinical Trial Registry, and are now ready to be delivered to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries were it will be carried out.
Borja Robert
10 months ago